Pfizer ( PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and sending the stock down about 1% in premarket trading.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback